@article{acdbbd003354484fbed2ceed861685db,
title = "Anti-inflammatory reliever therapy for asthma",
author = "Brian Lipworth and Rory Chan and {RuiWen Kuo}, Chris",
note = " Dr Lipworth reported receiving grants, personal fees, and nonfinancial support from Astra Zeneca (UK); grants, personal fees, and nonfinancial support from Chiesi (Italy); and other support from GSK (UK) during the conduct of the study and grants, personal fees, and nonfinancial support from Boehringer Ingelheim (Germany) and personal fees from Sanofi (France), Teva (Israel), Novartis (Switzerland), Cipla (India), Circassia (UK), Vectura (UK), Glenmark (UK), Dr Reddys (India), Lupin (USA), Genentech (USA), outside the submitted work. Dr Kuo reported receiving personal fees from Circassia (UK) and AstraZeneca (UK) outside the submitted work. No other disclosures were reported.",
year = "2020",
month = jan
doi = "10.1016/j.anai.2019.10.002",
language = "English",
volume = "124",
pages = "13--15",
journal = "Annals of Allergy, Asthma & Immunology",
issn = "1081-1206",
publisher = "Elsevier",
number = "1",
}